The COVID-19 pandemic changed all of our lives in 2020. Development of a COVID-19 vaccine required some re-thinking of the standard vaccine development paradigm. The webinar will cover nonclinical development of the Pfizer-BioNTech CoVID-19 vaccine as well as some aspects specifically related to developing an mRNA vaccine and how that differed from a typical infectious disease nonclinical development program.
1. Provide brief overview of the typical approach to infectious disease vaccine development
2. Describe approach used for COVID-19 vaccine nonclinical development during a pandemic
3. Outline some points to consider in mRNA vaccine nonclinical development